TPO Combined With TPORA for Solid Tumors Effectiveness of cTit Above Degree II

Not yet recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
CTIT-Chemotherapy Induced Thrombocytopenia
Interventions
DRUG

Basal therapy

Group A was treated with basal therapy including drugs such as interleukin-11, Ricocin, and Epsilon, and was administered until the PLT was ≥75×109/L.

DRUG

rhTPO combined with Heptabopa treatment(group B)

In group B, they were treated with rhTPO and Heptabopa, and were medicated until their PLT was ≥75×109/L.

DRUG

rhTPO combined with Heptabopa treatment(group C)

Ctit patients with platelet counts \<50×109/L were included in group C. All were treated with rhTPO and hypertrombopa and medicated until PLT ≥75×109/L.

All Listed Sponsors
lead

Jinhua Central Hospital

OTHER

NCT06769685 - TPO Combined With TPORA for Solid Tumors Effectiveness of cTit Above Degree II | Biotech Hunter | Biotech Hunter